drugset / Trial / NCT01199900

Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism

NCT01199900

Phase 1 Completed 18 enrolled Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

This study will investigate the effect of a single dose of PF-04171327 or prednisone on calculated measures of glucose tolerance and insulin resistance by using a modified oral glucose tolerance test

Timeline

Start
2010-08
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisone Other / unclassified 5 mg
Comparator Prednisone Other / unclassified 20 mg
Subject fosdagrocorat Small molecule 3 mg Oral
Subject fosdagrocorat Small molecule 10 mg Oral
Subject fosdagrocorat Small molecule 25 mg Oral

Indications

No indication recorded.